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Protein pyrophosphorylation: moving forward
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Genetic ablation of inositol pyrophosphate synthesis has established the fundamental
importance of this class of molecules to the eukaryote cell. These studies, however, must
be complemented by cell biology and biochemical approaches to appreciate the signal-
ling involved in the processes regulated by inositol pyrophosphates. A recent study by
Chanduri et al. published in the Biochemical Journal, by integrating multiple experimental
approaches, demonstrated that inositol pyrophosphates regulate intracellular vesicular
movement. In particular, the vesicular transport along the microtubule that is driven by
the motor protein complex dynein. Importantly, one subunit of this cellular motor, dynein
1 intermediate chain 2, undergoes serine pyrophosphorylation, a post-translational modi-
ﬁcation driven by inositol pyrophosphates. The pyrophosphorylation status of this dynein
intermediate chain regulates its interaction with dynactin, which recruits the motor to vesi-
cles. This mechanistically might explain how inositol pyrophosphates control intracellular
membrane trafﬁcking. By dissecting the serine pyrophosphorylation process, this work
increases our awareness of this modiﬁcation, underappreciated by the scientiﬁc literature
but probably not by the eukaryotic cell.
The ever-growing interest in the inositol pyrophosphates as signalling and metabolic messengers is
fully justiﬁed by the many unique and exciting features this class of molecule possesses. Inositol pyro-
phosphates are ubiquitously present in eukaryotes, turn over very rapidly and, most importantly,
contain one or more high-energetic pyrophosphate moiety/ies, hence their name [1]. Furthermore,
this class of molecules appears to regulate a wide range of cell biological processes, and thus it has
been proposed that inositol pyrophosphates might control a fundamental cellular function. Studies
indicate that inositol pyrophosphates regulate basic metabolism [1,2] such as cellular energetics [3] or
phosphate homeostasis [4,5]. While there is a continued proliferation of processes known to be regu-
lated by inositol pyrophosphates, the most intriguing and controversial aspect of this research ﬁeld is
the mechanism/s of action by which this class of molecules exercise its functions [6]. Inositol pyro-
phosphate may affect protein function allosterically by binding; this represents the accepted mechan-
ism of action of other inositol polyphosphates such as inositol trisphosphate (IP3), which releases
calcium from intracellular stores by binding to the IP3 receptor. However, while there is a growing
number of proteins shown to have inositol pyrophosphate-binding capability, the speciﬁc and selectiv-
ity of this process is vulnerable given the extraordinary charge density possessed by this class of mole-
cules. An alternative mechanism of action relies on the distinctive presence of the pyrophosphate
moiety. In this model (Figure 1), an ATP kinase, usually casein kinase 2 (CK2), pre-phosphorylates
and primes a target serine residue. Subsequently, the hydrolysis of the highly energetic pyrophosphate
moiety drives the non-enzymatic transfer of the β-phosphate to the phosphorylated serine, forming a
pyrophosphoserine [7,8]. The two mechanisms of action are not mutually exclusive and can coexist in
cells. Studying protein pyrophosphorylation is technically challenging. First and foremost, it requires
the synthesis of 32P-radiolabelled inositol pyrophosphates such as radiolabelled 5-diphosphoinositol
pentakisphosphate (5-[β-32P]IP7); although straightforward, preparing one’s own radiolabelled chemicals
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requires a commitment not commonly found in today’s young researchers. Consequently, any effort aiming to
study protein pyrophosphorylation is commendable, including the report by Chanduri et al. [9] published in a
recent issue of the Biochemical Journal.
Chanduri et al. [9] mainly, but not exclusively, used the genetic model of mouse embryonic ﬁbroblasts
(MEFs) derived from ip6k1−/− mice in their study. The knockout of IP6K1 (inositol hexakisphosphate kinase 1)
results in a decrease of inositol pyrophosphate levels in ip6k1−/− MEFs [10]. Using a classical experimental
approach, namely transferrin uptake, it was observed that while transferrin’s immediate entry was unaffected,
its accumulation in the perinuclear endocytic recycling compartment (ERC) was dramatically reduced in
ip6k1−/− MEFs. Studying the co-localization of transferrin with the early endosomal marker EEA1 revealed that
the degree of EEA1–transferrin co-localization was higher in ip6k1−/− MEFs compared with ip6k1+/+ MEFs
(wild-type, WT). This indicates that transferrin’s exit from early endosomes is delayed in ip6k1−/− MEFs. The
expression of active, but not inactive, IP6K1 rescued these defects, demonstrating that inositol pyrophosphates
are required for endosomal sorting of transferrin and its accumulation in the ERC. Furthermore, Chanduri
et al. [9] have tracked vesicular movement in vivo using a speciﬁc ﬂuorescence sensor, demonstrating that the
speed of ﬂuorescent endosomes is signiﬁcantly lower in ip6k1−/− MEFs. Another assay used by the authors to
demonstrate altered intracellular vesicular movement is phagosome distribution. After allowing latex beads to
be phagocytized by primary macrophages isolated from ip6k1−/− and WT mice, a greater number of phago-
somes in nuclear proximity was observed in macrophages collected from WT mice [9].
Phagosome movement and transferrin transport from early endosomes to the ERC occur along cytoskeletal
microtubules in a dynein-dependent manner. The motor protein dynein comprises two heavy chains with
ATPase activity, responsible for generating the movement, and several smaller proteins important in stabilizing
the macromolecular complex, and for cargo docking. One of these proteins, cytoplasmic dynein 1 intermediate
chain 2 (DYNC1I2 or IC-2C), possesses a pyrophosphorylation consensus sequence characterized by one or
more serines embedded in a streak of acidic amino acids [7]. This type of sequence also represents the
canonical phosphorylation site for CK2, an event necessary to pre-phosphorylate and prime the target serine
Figure 1. Protein pyrophosphorylation is generate by a two-step mechanism.The serine residue (S, bold) is initially
phosphorylated by CK2 that generates a phosphoserine residue using ATP (P, blue). Subsequently, inositol pyrophosphates,
such as diphosphoinositol pentakisphosphate (IP7) (P, red), transfer the β-phosphate of the pyrophosphate moiety to the
phosphoserine in a non-enzymatic manner, generating a pyrophosphoserine residue and inositol hexakisphosphate (IP6).
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for pyrophosphorylation [7]. Mutagenesis of this putative target site (serine-51 in mouse IC-2C sequence)
to alanine abolished IC-2C pyrophosphorylation. However, the mutagenesis also abolished the CK2
pre-phosphorylation event. Therefore, to overcome this problem and to assess whether IC-2C undergoes pyro-
phosphorylation in vivo, the authors carried out a ‘back-pyrophosphorylation’ assay [11]. The logic of this
assay relies on the assumption that pyrophosphorylation target proteins isolated from WT MEFs are already
pyrophosphorylated in vivo, whereas target proteins isolated from ip6k1−/− MEFs are not. Consequently, on
performing the back-pyrophosphorylation assay in vitro on proteins puriﬁed from WT or ip6k1−/− MEFs,
these target proteins will show a differential incorporation of radiolabelled phosphate inversely proportional to
the amount of in vivo pyrophosphorylation. Indeed, incubation of radiolabelled inositol pyrophosphate
5-[β-32P]IP7 with immunoprecipitated IC-2C resulted in virtually no pyrophosphorylation of WT-derived
IC-2C, indicating that the protein is in vivo pyrophosphorylated and cannot be further pyrophosphorylated in
vitro. Conversely, IC-2C immunoprecipitated from ip6k1−/− MEF extracts was promptly radiolabelled in vitro,
indicating that in these cells this protein is poorly pyrophosphorylated or non-pyrophosphorylated [9].
How does IC-2C pyrophosphorylation status affect vesicular movement? The IC-2C pyrophosphorylation
site is located in a region that interacts with the subunit p150Glued of the dynactin complex. The authors
demonstrated using pull-down experiments as well as co-immunoprecipitation of endogenous proteins that the
pyrophosphorylation status of IC-2C positively regulates its interaction with p150Glued. In other words, in WT
MEFs, the association between IC-2C and p150Glued is stronger than that in ip6k1−/− MEFs. Dynactin regulates
the binding of dynein to intracellular organelles, such as endosomes and phagosomes, which are then
transported along microtubules. Therefore, the IC-2C pyrophosphorylation status affects motor protein
docking to vesicles, explaining the impaired dynein-dependent vesicle transport observed in ip6k−/− cells.
The work of Chanduri et al. [9] adds to the small handful of studies that have investigated protein pyrophos-
phorylation [7–9,11,12]. The pyrophosphorylation of serine residues, while exciting, is a concept surrounded by
justiﬁed scepticism. The criticism surrounding this post-translational modiﬁcation is understandable and
appropriate, since there is no direct evidence supporting the existence of this post-translational modiﬁcation in
vivo. It is relatively simple to verify whether a protein is pyrophosphorylated in vitro using radiolabelled 5-[β-32P]IP7.
It is also reasonably simple to perform a ‘back-pyrophosphorylation’ assay. This analysis, however, presupposes
that serine pyrophosphorylation exists in vivo in the ﬁrst place; while this seems logical, it might not be the
case. Therefore, back-pyrophosphorylation is an indirect assay and prone to uncertainty and criticism. The
dissection of another indirect in vivo evidence of protein pyrophosphorylation, in-gel mobility shift, resulted in
connecting the mobility shift to a different protein post-translational modiﬁcation, lysine polyphosphorylation,
and not to serine pyrophosphorylation [13]. Therefore, it becomes imperative to demonstrate the direct pres-
ence of pyrophosphoserine peptides by mass spectrometry. Initially, it would be important to demonstrate the
existence of pyrophosphoserine residues in peptides pyrophosphorylated in vitro. However, the ultimate proof
will come by demonstrating the presence of pyrophosphoserine in proteins extracted from cells, thus pyrophos-
phorylated in vivo by the dynamic inositol pyrophosphate cellular metabolism. These important objectives are
getting closer since they are now facilitated by the viability of chemically synthesized inositol pyrophosphates,
by their delivery into cells [14,15], and by the development of several newly generated chemical tools that
target the synthesis and detection of pyrophosphorylated peptides [16].
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